Table 2.
Author | Adherence measure | Adherence cut off |
---|---|---|
Diabate et al. [67] | Self report with ACTGa | ≥ 95% |
Carlucci et al. [68] | Pill count | ≥ 95% |
Fielding et al. [69] | Self report | 100% reported adherence in last 3 days |
Birbeck et al. [70] | Attendance at clinic and self report | Attended all scheduled ART clinic visits with no lapse in drug collection and documentation |
Pirkle et al. [71] | Self-report | N/A |
Stubbs et al. [72] | Pill count | ≥ 90% |
Jaquet et al. [73] | Self report with ACTGa | ≥ 95% |
Lester et al. [74] | Self report—asked how many pills missed in 30 days | ≥ 95% |
Watt et al. [75] | Self report with ACTGa | ≥ 95% |
Chung et al. [76] | Pill count | ≥ 95% |
Kunutsor et al. [77] | Pill count | ≥ 95% |
Messou et al. [78] | Pill count | ≥ 95% |
Ncaca et al. [79] | Medication possession ratio | ≥ 95% |
Mbuagbaw et al. [80] | Self report using visual analogue scale | ≥ 95% |
Annison et al. [81] | Self report | Patients without treatment interruptions |
Kiwuwa-Muyingo et al. [82] | Pill count and structured questionnaire | Good adherence defined as “did not miss a dose in last month” |
Negash et al. [83] | Self report of medication doses taken divided by medication doses prescribed | ≥ 95% |
Jones et al. [84] | Self report using ACTGa | Adherence over last two weeks |
Vinikoor et al. [39] | Medication Possession ratio | ≥ 95% |
Muya et al. [38] | Compliance with pick-up visits | ≥ 95% |
aAIDS Clinical Trial Group Adherence Questionnaire [34]